Protecting Americans with Pre-existing Conditions Act of 2019
The source supplies the latest action, but no lifecycle stage.
Latest action (13 Feb 2019): Read twice and referred to the Committee on Finance.
What this bill does
The Protecting Americans with Pre-existing Conditions Act of 2019, introduced in the Senate, aims to nullify specific guidance related to state innovation waivers under the Affordable Care Act. If enacted, it would prevent the Secretaries of Health and Human Services and the Treasury from implementing or enforcing the "State Relief and Empowerment Waivers" guidance, which was published in October 2018, and prohibit similar future guidance.
This bill would affect states seeking to use these particular waivers to innovate their healthcare systems and potentially impact individuals who rely on protections for pre-existing conditions under the Affordable Care Act. The bill was introduced on February 13, 2019, and has been referred to the Committee on Finance. It did not receive a vote in the 116th Congress and has not advanced further in the legislative process.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Protecting Americans with Pre-existing Conditions Act of 2019
This bill nullifies the Department of the Treasury and the Department of Health and Human Services guidance titled "State Relief and Empowerment Waivers," published on October 24, 2018. The guidance pertains to Section 1332 waivers (also known as State Innovation Waivers or State Relief and Empowerment Waivers), which allow states to forego certain requirements of the Patient Protection and Affordable Care Act in order to implement experimental plans for health care coverage, as long as the resulting coverage meets certain statutory criteria.
The guidance, which supersedes earlier guidance from 2015, alters agency interpretation of how states may satisfy the statutory criteria for waiver approval. For example, the guidance (1) redefines acceptable coverage under such waivers to include short-term, limited-duration insurance and association health plans; (2) allows the comprehensiveness and affordability of coverage under such waivers to be assessed based on projected availability, rather than enrollment; and (3) allows the level of coverage to be assessed based on the effects over the entire course of the waiver, rather than per year.
Timeline
13 Feb 2019
Read twice and referred to the Committee on Finance.
Common questions
- What does S. 466 do?
- The Protecting Americans with Pre-existing Conditions Act of 2019, introduced in the Senate, aims to nullify specific guidance related to state innovation waivers under the Affordable Care Act. If enacted, it would prevent the Secretaries of Health and Human Services and the Treasury from implementing or enforcing the "State Relief and Empowerment Waivers" guidance, which was published in October 2018, and prohibit similar future guidance. This bill would affect states seeking to use these particular waivers to innovate their healthcare systems and potentially impact individuals who rely on protections for pre-existing conditions under the Affordable Care Act. The bill was introduced on February 13, 2019, and has been referred to the Committee on Finance. It did not receive a vote in the 116th Congress and has not advanced further in the legislative process.
- Has S. 466 become law?
- The source does not supply a confirmed lifecycle stage for S. 466. Check the latest action and official source below.
- Who sponsored S. 466?
- S. 466 was sponsored by Sen. Warner, Mark R. [D-VA] (D-VA), with 23 cosponsors.
- What's the latest action on S. 466?
- Read twice and referred to the Committee on Finance. (13 Feb 2019).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Warner, Mark R. [D-VA]
Ensuring Accurate Payments to Specialty Pharmacies Act
Artificial Intelligence Risk Management and Security Act of 2026
Alpha-gal Allergen Inclusion Act
STOP TICKS Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.